Baird analyst Eric Coldwell upgraded Cardinal Health to Outperform from Neutral with a price target of $94, up from $87.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CAH:
- Cardinal Health raises FY23 EPS view to $5.20-$5.50 from $5.05-$5.40
- Cardinal Health reports Q2 EPS $1.32, consensus $1.14
- Cardinal Health Reports Second Quarter Fiscal Year 2023 Results and Raises Fiscal Year 2023 Non-GAAP EPS Guidance
- Notable companies reporting before tomorrow’s open
- Cardinal Health price target raised to $91 from $78 at UBS